rxstat › Drug prices › Lixisenatide Insulin Glargine

Lixisenatide Insulin Glargine (Soliqua) price in Canada

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Lixisenatide Insulin Glargine 100 unit/ml / 33 mcg/ml solution costs about $206.60 per billed unit (often a pen or vial) on public drug plan price lists in Ontario, before the pharmacy's dispensing fee.

Lixisenatide Insulin Glargine has no current shortage reported in Canada. No active reports are on file.

Price by province

Strength and formABSKON
100 unit/ml / 33 mcg/ml Solution$13.50/mLnot covered$202.53/unit$206.60/unit
Plan coverageNot coveredSpecial approvalCovered

Lowest price per unit among each province's covered products, with the brand price where it is notably higher. A dash means the province does not list it. Provinces bill some products (injectables especially) per mL and others per pen or vial, so compare prices with the same unit.

Detailed price and coverage in your province:

What you'll pay at the pharmacy

These are the prices public drug plans list for the drug itself. At the counter, pharmacies add a dispensing fee and in some provinces a markup, so paying cash costs more, and for cheap generics the fee is often more than the drug. If you have a public or private plan, your share depends on its deductible and co-pay.

Listed products by province

Alberta: 1 product
  • Soliqua 100 unit/ml / 33 mcg/ml Solution · SAV
    DIN 02478293 · $13.50/mL · Not covered
Saskatchewan: 1 product
  • Soliqua 100 unit/ml / 33 mcg/ml Solution · AVT
    DIN 02478293 · $202.53/unit · Special approval
Ontario: 1 product
  • Soliqua 100 unit/ml / 33 mcg/ml Solution · Sanofi-Aventis Canada Inc.
    DIN 02478293 · $206.60/unit · Covered

Price sources: Ontario Drug Benefit Formulary (Oct 30, 2026) · Alberta Drug Benefit List and Alberta Blue Cross price list (Nov 1, 2026) · Saskatchewan Drug Plan Formulary (Nov 1, 2026). Other provinces and territories will be added as their public price lists are brought in.

Shortage status

Products affected
0 / 1
Reports on file
1

Reports by product

Resolved
SOLIQUA
33MCG 100UNIT · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02478293 · ended Aug 3, 2022

What's happening

There are no active shortage reports for Lixisenatide Insulin Glargine.

Recent changes

Common questions

How much does Lixisenatide Insulin Glargine cost in Canada?

Lixisenatide Insulin Glargine 100 unit/ml / 33 mcg/ml solution costs about $206.60 per billed unit (often a pen or vial) on public drug plan price lists in Ontario, before the pharmacy's dispensing fee.

Is Lixisenatide Insulin Glargine covered by provincial drug plans?

On the public plans' own lists: Alberta: not covered; Saskatchewan: special approval; Ontario: covered. "Special approval" means the plan covers it only for some patients, on a request from the prescriber. "Price list" means the province publishes its price but not its coverage.

When will Lixisenatide Insulin Glargine be back in stock in Canada?

Lixisenatide Insulin Glargine has no active shortage; supply is normal per Health Canada reports.

Why is Lixisenatide Insulin Glargine in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.